About Careers MedBlog Contact us

Removing Extra Tissue During Breast Cancer Surgery Cuts Reoperation Rate by 50%

by Shirley Johanna on June 3, 2015 at 6:29 PM
Font : A-A+

Removing Extra Tissue During Breast Cancer Surgery Cuts Reoperation Rate by 50%

Removing an extra millimeter or two of surrounding tissue during breast cancer surgery can reduce the chance for follow-up surgery by half, according to a team of Yale researchers.

More than 230,000 women are diagnosed with breast cancer each year in the United States. In most cases, majority of the women undergo surgery to remove the tumor rather than the entire breast. However, between 20 percent and 40 percent of patients who undergo this procedure have "positive margins", or cancer cells found at the edge of what is removed.


The presence of positive margins often leads to a second surgery to remove the cancer remains. 

The researchers explored how removing more tissue around the tumor site during initial surgery known as cavity shave margins (CSM) could reduce the need for a second surgery. The study tested cavity shaving, 235 patients with breast cancer were given usual breast cancer surgery. Patients were then randomized in the operating room to get the extra cavity shave.

"With a very simple technique of taking a little more tissue at the first operation we can reduce the chances that somebody would need to go back to the operating room a second time by 50 percent. When you think about the emotional impact, let alone the economic impact, of those second surgeries, that's a big deal," said the study leader, Yale Cancer Center's Dr. Anees Chagpar.

Only 10 percent of women who had extra tissue removed needed a second surgery versus 21 percent of the others.

Chagpar said the results of the study are strong enough that many surgeons may adopt the new technique.

Source: Medindia


Recommended Reading

Latest Cancer News

 Weed Killer Agent Orange May Increase the Risk of Blood Cancer Among Veterans
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
Hope for Lethal Brain Tumors: Targeted Therapy Delays Glioma Progression
A ray of hope for glioma patients as targeted therapy boosts treatment duration.
Is Adding Ribociclib to Hormone Therapy Improves Breast Cancer Outcomes
In patients with breast cancer combination therapy had increased invasive disease-free survival compared to those who were treated with the hormone therapy alone.
Antibody Treatment Proves Effective for Bile Duct Cancers
An antibody treatment helped shrink tumors in some patients with bile duct cancers.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Removing Extra Tissue During Breast Cancer Surgery Cuts Reoperation Rate by 50% Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests